Department of General Surgery, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Shanghai Research Center of Biliary Tract Disease, Shanghai, China.
EMBO Rep. 2017 Oct;18(10):1837-1853. doi: 10.15252/embr.201744147. Epub 2017 Sep 8.
Long noncoding RNAs (lncRNAs) play roles in the development and progression of many cancers; however, the contributions of lncRNAs to human gallbladder cancer (GBC) remain largely unknown. In this study, we identify a group of differentially expressed lncRNAs in human GBC tissues, including prognosis-associated gallbladder cancer lncRNA (lncRNA-PAGBC), which we find to be an independent prognostic marker in GBC Functional analysis indicates that lncRNA-PAGBC promotes tumour growth and metastasis of GBC cells. More importantly, as a competitive endogenous RNA (ceRNA), lncRNA-PAGBC competitively binds to the tumour suppressive microRNAs miR-133b and miR-511. This competitive role of lncRNA-PAGBC is required for its ability to promote tumour growth and metastasis and to activate the AKT/mTOR pathway. Moreover, lncRNA-PAGBC interacts with polyadenylate binding protein cytoplasmic 1 (PABPC1) and is stabilized by this interaction. This work provides novel insight on the molecular pathogenesis of GBC.
长链非编码 RNA(lncRNAs)在许多癌症的发生和发展中发挥作用;然而,lncRNAs 对人类胆囊癌(GBC)的贡献在很大程度上仍不清楚。在这项研究中,我们鉴定了一组在人 GBC 组织中差异表达的 lncRNAs,包括与预后相关的胆囊癌 lncRNA(lncRNA-PAGBC),我们发现其是 GBC 的独立预后标志物。功能分析表明,lncRNA-PAGBC 促进 GBC 细胞的肿瘤生长和转移。更重要的是,作为竞争性内源性 RNA(ceRNA),lncRNA-PAGBC 竞争性结合肿瘤抑制性 microRNAs miR-133b 和 miR-511。lncRNA-PAGBC 的这种竞争作用对于其促进肿瘤生长和转移以及激活 AKT/mTOR 通路是必需的。此外,lncRNA-PAGBC 与多聚腺苷酸结合蛋白细胞质 1(PABPC1)相互作用并通过这种相互作用得到稳定。这项工作为 GBC 的分子发病机制提供了新的见解。